"Kliinilised uuringud erinevate haiguste ära hoidmiseks ja ravi leidmiseks."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Galapagos NV
3
Amgen
2
Symic OA Co.
2
Boehringer Ingelheim
1
Janssen Research & Development, LLC
1
Janssen Vaccines & Prevention B.V.
1
ModernaTX, Inc.
1
Pfizer
1
Seqirus
1
Unigene Laboratories Inc.
1
mAbxience Research S.L.
1
Clinical Trials at Center for Clinical and Basic Research
During the past decade, Center for Clinical and Basic Research conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 3 clinical trials were completed, i.e. on
average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40%
of trials that started reached the finish line.
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Center for Clinical and Basic Research" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Amgen" with 2 trials
sponsored, "Symic OA Co." with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Janssen Research & Development, LLC"
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Clinical and Basic Research"
#1 collaborator was "Gilead Sciences" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Nordic Bioscience A/S" with 1 trials as a collaborator and "Nordic Bioscience Clinical Development" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Center for Clinical and Basic Research
According to Clinical.Site data, the most researched conditions in "Center for Clinical and Basic Research" are
"Psoriatic Arthritis" (4 trials), "Osteoarthritis" (2 trials), "Ankylosing Spondylitis" (1 trials), "Arthritis, Psoriatic" (1 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Center for Clinical and Basic Research" in a lesser frequency.
Clinical Trials Intervention Types at Center for Clinical and Basic Research
Most popular intervention types in "Center for Clinical and Basic Research" are "Drug" (9 trials), "Other" (4 trials), "Biological" (3 trials), "Device" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "SB-061" (2 trials), "filgotinib" (2 trials), "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials) and "BI 695501" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Center for Clinical and Basic Research
The vast majority of trials in "Center for Clinical and Basic Research" are
12 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Center for Clinical and Basic Research
Currently, there are NaN active trials in "Center for Clinical and Basic Research".
undefined are not yet recruiting,
3 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Center for Clinical and Basic Research,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Center for Clinical and Basic Research, 2 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".